Huatainuo Biology
Latest round
- Series B
Last raised
- Mar 2024
Total raised
- $103M
Investors
- 10
About Huatainuo Biology
Based in Beijing, China and established in 2019, Huatainuo Biology is a biotechnology company that develops vaccine., Ltd., Ltd. The company has its headquarters and R&D center in Beijing, a new adjuvant production facility in Chengdu, and a vaccine production facility in Taizhou. As of 2024, the company has nearly 30 tons of raw materials for adjuvant production and can produce nearly 30 varieties of new adjuvants. The company is dedicated to the development and industrialization of human vaccine products and innovative adjuvants. The company's self-developed products such as peptide therapeutic vaccine HN201, recombinant protein vaccine HN101, and broad-spectrum recombinant protein vaccine HN103. Its products are used to treat Covid-19, influenza, malaria and shingles, and so on.
Who invested in Huatainuo Biology
10 investors across 2 rounds
See all investors in Huatainuo Biology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Huatainuo Biology
Who invested in Huatainuo Biology?
Huatainuo Biology has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Huatainuo Biology raised?
Huatainuo Biology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Huatainuo Biology last raise money?
Huatainuo Biology's most recent round on record is a Series B, in Mar 2024.
What does Huatainuo Biology do?
Based in Beijing, China and established in 2019, Huatainuo Biology is a biotechnology company that develops vaccine.
Where is Huatainuo Biology headquartered?
Huatainuo Biology is headquartered in Beijing, China.
Which VCs invest in companies like Huatainuo Biology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Huatainuo Biology's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Huatainuo Biology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.